307 related articles for article (PubMed ID: 19728082)
1. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.
Garwood ER; Kumar AS; Baehner FL; Moore DH; Au A; Hylton N; Flowers CI; Garber J; Lesnikoski BA; Hwang ES; Olopade O; Port ER; Campbell M; Esserman LJ
Breast Cancer Res Treat; 2010 Jan; 119(1):137-44. PubMed ID: 19728082
[TBL] [Abstract][Full Text] [Related]
2. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
[TBL] [Abstract][Full Text] [Related]
3. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
[TBL] [Abstract][Full Text] [Related]
4. Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels.
Schneider MP; Schmidt BM; John S; Schmieder RE
J Hypertens; 2011 Sep; 29(9):1757-64. PubMed ID: 21799442
[TBL] [Abstract][Full Text] [Related]
5. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
Bjarnadottir O; Romero Q; Bendahl PO; Jirström K; Rydén L; Loman N; Uhlén M; Johannesson H; Rose C; Grabau D; Borgquist S
Breast Cancer Res Treat; 2013 Apr; 138(2):499-508. PubMed ID: 23471651
[TBL] [Abstract][Full Text] [Related]
6. A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer.
Longo J; Hamilton RJ; Masoomian M; Khurram N; Branchard E; Mullen PJ; Elbaz M; Hersey K; Chadwick D; Ghai S; Andrews DW; Chen EX; van der Kwast TH; Fleshner NE; Penn LZ
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):630-637. PubMed ID: 32203069
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.
Holdaas H; Jardine AG; Wheeler DC; Brekke IB; Conlon PJ; Fellstrøm B; Hammad A; Holme I; Isoniemi H; Moore R; Rowe PA; Sweny P; Talbot DA; Wadstrøm J; Østraat Ø
Kidney Int; 2001 Nov; 60(5):1990-7. PubMed ID: 11703619
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin and perioperative events in patients undergoing vascular surgery.
Schouten O; Boersma E; Hoeks SE; Benner R; van Urk H; van Sambeek MR; Verhagen HJ; Khan NA; Dunkelgrun M; Bax JJ; Poldermans D;
N Engl J Med; 2009 Sep; 361(10):980-9. PubMed ID: 19726772
[TBL] [Abstract][Full Text] [Related]
9. A Clinical Study Evaluating the Effects of Fluvastatin on Serum Osteoprotegerin Levels in Rheumatoid Arthritis Patients.
Hegazy SK; El-Ghany El-Sayed Sel-M; El-Hefnawy Mel-S
J Clin Pharmacol; 2016 Oct; 56(10):1272-6. PubMed ID: 26899523
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.
Nasu K; Tsuchikane E; Katoh O; Tanaka N; Kimura M; Ehara M; Kinoshita Y; Matsubara T; Matsuo H; Asakura K; Asakura Y; Terashima M; Takayama T; Honye J; Hirayama A; Saito S; Suzuki T
JACC Cardiovasc Interv; 2009 Jul; 2(7):689-96. PubMed ID: 19628194
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
Davidson MH; Palmisano J; Wilson H; Liss C; Dicklin MR
Clin Ther; 2003 Nov; 25(11):2738-53. PubMed ID: 14693301
[TBL] [Abstract][Full Text] [Related]
12. Fluvastatin increases LDL particle size and reduces oxidative stress in patients with hyperlipidemia.
Yoshino G; Hirano T; Kazumi T; Takemoto M; Ohashi N
J Atheroscler Thromb; 2003; 10(6):343-7. PubMed ID: 15037823
[TBL] [Abstract][Full Text] [Related]
13. Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
Feldt M; Bjarnadottir O; Kimbung S; Jirström K; Bendahl PO; Veerla S; Grabau D; Hedenfalk I; Borgquist S
J Transl Med; 2015 Apr; 13():133. PubMed ID: 25925673
[TBL] [Abstract][Full Text] [Related]
14. Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension.
Hartner A; Klanke B; Cordasic N; Amann K; Schmieder RE; Veelken R; Hilgers KF
J Hypertens; 2009 Feb; 27(2):376-85. PubMed ID: 19226708
[TBL] [Abstract][Full Text] [Related]
15. Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics.
Fauler G; Abletshauser C; Erwa W; Löser R; Witschital K; März W
Int J Clin Pharmacol Ther; 2007 Jun; 45(6):328-34. PubMed ID: 17595890
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels.
Spieker LE; Noll G; Hannak M; Lüscher TF
J Cardiovasc Pharmacol; 2000 Mar; 35(3):361-5. PubMed ID: 10710119
[TBL] [Abstract][Full Text] [Related]
17. Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells.
Goard CA; Chan-Seng-Yue M; Mullen PJ; Quiroga AD; Wasylishen AR; Clendening JW; Sendorek DH; Haider S; Lehner R; Boutros PC; Penn LZ
Breast Cancer Res Treat; 2014 Jan; 143(2):301-12. PubMed ID: 24337703
[TBL] [Abstract][Full Text] [Related]
18. Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.
Tekin A; Sezgin N; Katircibaşi MT; Tekin G; Cölkesen Y; Sezgin AT; Müderrisoğlu H
Coron Artery Dis; 2008 Nov; 19(7):513-9. PubMed ID: 18923248
[TBL] [Abstract][Full Text] [Related]
19. A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction.
Seeger JD; Walker AM; Williams PL; Saperia GM; Sacks FM
Am J Cardiol; 2003 Dec; 92(12):1447-51. PubMed ID: 14675584
[TBL] [Abstract][Full Text] [Related]
20. Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer.
Bhardwaj A; Embury MD; Ju Z; Wang J; Bedrosian I
BMC Cancer; 2022 Mar; 22(1):282. PubMed ID: 35296281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
